House
RoundsGuidelinesCalculatorsPricing
Sign inCreate account→
House

Citation-backed clinical intelligence for verified physicians.

Product

  • Rounds
  • Guidelines
  • Calculators
  • Pricing

Company

  • About
  • Editorial Policy

© 2026 House

For verified, licensed physicians. Not a substitute for clinical judgement.

Back to guidelines
Cardiology · NICE

Hypertension in adults

NICE
A
Source:NICE NG136 Hypertension in adults: diagnosis and management (last updated November 2023)
Verified Apr 2026
Ask House about this guideline

Red Flags

  • BP ≥180/120 with retinal haemorrhages, papilloedema, or new acute end-organ damage — same-day specialist assessment[1]
  • Suspected phaeochromocytoma (labile BP, headaches, sweating, palpitations) — endocrine workup before treatment escalation[1]
  • Pregnancy with BP ≥140/90 — same-day obstetric medicine review[1]
  • Resistant hypertension uncontrolled on optimal triple therapy — investigate secondary causes; consider spironolactone (PATHWAY-2)[1]

First-line treatment

Interventions

  • Stepped therapy (A → A+C → A+C+D → resistant)[1]
    Step 1 (A or C per algorithm) → Step 2 (A+C) → Step 3 (A+C+D) → Step 4 add spironolactone or alpha-/beta-blocker
  • Lifestyle modification[1]
    Salt <6 g/day, healthy diet, regular activity, weight reduction, alcohol moderation, smoking cessation

First-line drug therapy

DrugClassAdultPaediatricNotes
Amlodipine (CCB)[1]Calcium channel blocker5–10 mg PO once daily—Step 1 if age ≥55 OR Black African / African-Caribbean origin (any age) without T2DM
Ramipril or losartan[1]ACE inhibitor or ARBRamipril 1.25–10 mg daily; losartan 50–100 mg daily—Step 1 if age <55 without Black African/Caribbean origin, OR T2DM at any age. ARB preferred over ACE-i in Black African/Caribbean origin patients with T2DM
Indapamide[1]Thiazide-like diuretic1.5 mg sustained-release once daily OR 2.5 mg standard daily—Step 3 partner. Preferred over hydrochlorothiazide
Spironolactone (low-dose)[1]Aldosterone antagonist12.5–50 mg PO once daily; monitor K+ and creatinine 4 weeks after initiation—Step 4 in resistant hypertension if K+ ≤4.5 mmol/L (per PATHWAY-2)
Amlodipine (CCB)[1]
Calcium channel blocker
Adult
5–10 mg PO once daily
Paediatric
—
Step 1 if age ≥55 OR Black African / African-Caribbean origin (any age) without T2DM
Ramipril or losartan[1]
ACE inhibitor or ARB
Adult
Ramipril 1.25–10 mg daily; losartan 50–100 mg daily
Paediatric
—
Step 1 if age <55 without Black African/Caribbean origin, OR T2DM at any age. ARB preferred over ACE-i in Black African/Caribbean origin patients with T2DM
Indapamide[1]
Thiazide-like diuretic
Adult
1.5 mg sustained-release once daily OR 2.5 mg standard daily
Paediatric
—
Step 3 partner. Preferred over hydrochlorothiazide
Spironolactone (low-dose)[1]
Aldosterone antagonist
Adult
12.5–50 mg PO once daily; monitor K+ and creatinine 4 weeks after initiation
Paediatric
—
Step 4 in resistant hypertension if K+ ≤4.5 mmol/L (per PATHWAY-2)

Safety-net

  1. Take medication every day even when feeling well — hypertension is silent until target organs are damaged[1]
  2. Sudden severe headache, chest pain, vision changes, slurred speech, or one-sided weakness — call emergency services immediately[1]
  3. Bring your home BP record to every visit; HBPM helps detect white-coat and masked hypertension[1]

Referral criteria

  • BP ≥180/120 with retinal haemorrhages, papilloedema, or new acute end-organ damageSame-day specialist (acute medicine or hypertension clinic)[1]
  • Resistant hypertension uncontrolled on triple therapyHypertension clinic for secondary cause workup[1]
  • Pregnancy with BP ≥140/90Obstetric medicine same-day[1]
  • Suspected secondary cause (young age, abrupt onset, hypokalaemia, abdominal bruit, paroxysmal symptoms)Endocrinology or nephrology[1]

Clinical summary

Diagnosis and management of hypertension in adults via stepped pharmacotherapy with primary-care emphasis.

References

  1. 1.NICE NG136 Hypertension in adults: diagnosis and management (last updated November 2023) (2023)

On this page

  • Red flags
  • First-line treatment
  • Safety-net
  • Referral
  • References